Recoding method that removes inhibitory sequences and improves HIV gene expression
The invention relates to inhibitory nucleotide signal sequences or "INS" sequences in the genomes of lentiviruses. In particular the invention relates to the AGG motif present in all viral genomes. The AGG motif may have an inhibitory effect on a virus, for example by reducing the levels of, or maintaining low steady-state levels of, viral RNAs in host cells, and inducing and/or maintaining in viral latency. In one aspect, the invention provides vaccines that contain, or are produced from, viral nucleic acids in which the AGG sequences have been mutated. In another aspect, the invention provides methods and compositions for affecting the function of the AGG motif, and methods for identifying other INS sequences in viral genomes.
- Research Organization:
- Institute for Advanced Study, Princeton, NJ (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- FG02-90ER40542
- Assignee:
- Institute of Advanced Study (Princeton, NJ)
- Patent Number(s):
- 9,422,342
- Application Number:
- 12/373,605
- OSTI ID:
- 1303730
- Resource Relation:
- Patent File Date: 2007 Jul 12
- Country of Publication:
- United States
- Language:
- English
Similar Records
Genetic Selection for Context-Dependent Stochastic Phenotypes: Sp1 and TATA Mutations Increase Phenotypic Noise in HIV-1 Gene Expression
Structure and expression of the murine N-myc gene